Question

You are managing a hybrid project for developing a medical device, where regulatory compliance work follows a waterfall approach with formal documentation and sign-offs, while the user interface development uses Kanban. The regulatory team has just completed validation protocols that must be signed by the quality assurance director before UI testing can begin. However, the QA director is unexpectedly on medical leave for two weeks, and the UI team has already completed their work and is ready to begin testing. The QA director's delegate can review documents but doesn't have signature authority. What is the best approach?

Accepted Answer

Have the delegate review the validation protocols now and prepare a recommendation, then obtain the QA director's signature when they return while the UI team begins testing on lower-risk components

Answer

Escalate to executive management to grant temporary signature authority to the delegate so the validation protocols can be approved immediately

Answer

Have the UI team wait for the QA director's return to ensure full regulatory compliance before beginning any testing activities

Answer

Proceed with full testing based on the delegate's verbal approval and document the QA director's formal signature retroactively upon their return

PMP Practice Question: Process — Hybrid, Medium

More Process Questions